NASDAQ:SLHG - Skylight Health Group Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $5.50
  • Forecasted Upside: 729.94 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$0.66
+0.30 (1.20%)

This chart shows the closing price for SLHG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Skylight Health Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SLHG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SLHG

Analyst Price Target is $5.50
▲ +729.94% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Skylight Health Group in the last 3 months. The average price target is $5.50, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 729.94% upside from the last price of $0.66.

This chart shows the closing price for SLHG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Skylight Health Group.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/27/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/25/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/23/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/21/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/22/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/22/2022

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/1/2022Lake Street CapitalLower Price Target$6.00 ➝ $3.00High
1/4/2022MackieUpgradeHold ➝ BuyMedium
11/17/2021Raymond JamesDowngradeOutperform ➝ Market Perform$7.00 ➝ $4.50High
11/1/2021Echelon Wealth PartnersReiterated RatingSpeculative BuyLow
10/14/2021Northland SecuritiesInitiated CoverageOutperform$9.00High
8/30/2021Echelon Wealth PartnersReiterated RatingBuyMedium
8/18/2021Raymond JamesLower Price TargetOutperformC$9.00 ➝ C$7.00High
8/2/2021Lake Street CapitalInitiated CoverageBuy$8.00High
(Data available from 5/22/2017 forward)

News Sentiment Rating

0.78 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/24/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/23/2021
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
12/23/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/22/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/21/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/23/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/22/2022
  • 6 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/22/2022

Current Sentiment

  • 6 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Skylight Health Group logo
Skylight Health Group Inc. operates as a healthcare services and technology company in the United States, Canada, the United Kingdom, and Colombia. It operates the US multi-state primary care health network, which provides a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The company also owns and operates a proprietary electronic health record system that supports the delivery of care to patients through telemedicine and other remote monitoring system integrations. In addition, it offers a disruptive subscription-based telemedicine service for the un/under-insured population. The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.
Read More

Today's Range

Now: $0.66
Low: $0.62
High: $0.70

50 Day Range

MA: $0.95
Low: $0.61
High: $1.33

52 Week Range

Now: $0.66
Low: $0.55
High: $6.25

Volume

33,548 shs

Average Volume

257,164 shs

Market Capitalization

$26.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Skylight Health Group?

The following equities research analysts have issued research reports on Skylight Health Group in the last year: Echelon Wealth Partners, Lake Street Capital, Mackie, Northland Securities, Raymond James, and Zacks Investment Research.
View the latest analyst ratings for SLHG.

What is the current price target for Skylight Health Group?

0 Wall Street analysts have set twelve-month price targets for Skylight Health Group in the last year. Their average twelve-month price target is $5.50, suggesting a possible upside of 729.9%.
View the latest price targets for SLHG.

What is the current consensus analyst rating for Skylight Health Group?

Skylight Health Group currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SLHG will outperform the market and that investors should add to their positions of Skylight Health Group.
View the latest ratings for SLHG.

What other companies compete with Skylight Health Group?

How do I contact Skylight Health Group's investor relations team?

The company's listed phone number is (855) 874-4999 and its investor relations email address is [email protected] The official website for Skylight Health Group is www.skylighthealthgroup.com. Learn More about contacing Skylight Health Group investor relations.